These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6861868)

  • 1. Lack of dose dependent kinetics of theophylline.
    Brown PJ; Dusci LJ; Shenfield GM
    Eur J Clin Pharmacol; 1983; 24(4):525-7. PubMed ID: 6861868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose response relation to oral theophylline in severe chronic obstructive airways disease.
    Chrystyn H; Mulley BA; Peake MD
    BMJ; 1988 Dec; 297(6662):1506-10. PubMed ID: 3147048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two sustained-release theophylline preparations in adult patients with obstructive airways disease.
    Harkaway PS; Conlon PF; Hirsh JD; Allen WT
    J Clin Pharmacol; 1985 Sep; 25(6):444-7. PubMed ID: 4056079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of maintenance oral theophylline dosage using single oral doses in patients with obstructive airways disease.
    Taylor DR; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1983 Nov; 16(5):511-6. PubMed ID: 6639837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of optimum oral theophylline dose in patients with obstructive airways disease.
    Taylor DR; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1983 Jun; 15(6):689-94. PubMed ID: 6871068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-daily dosing of a new ultrasustained-release theophylline preparation.
    Van den Brande P; Nys J; Tjandramaga TB; Verhelst F; Demedts M
    Respiration; 1987; 52(2):144-53. PubMed ID: 3671893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent kinetics of theophylline in adults with pulmonary diseases.
    Massey KL; Gotz VP; Russell WL
    Ther Drug Monit; 1984; 6(3):284-9. PubMed ID: 6506135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prednisolone on theophylline pharmacokinetics in patients with chronic airflow obstruction.
    Fergusson RJ; Scott CM; Rafferty P; Gaddie J
    Thorax; 1987 Mar; 42(3):195-8. PubMed ID: 3616979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent kinetics for theophylline: observations among ambulatory asthmatic children.
    Sarrazin E; Hendeles L; Weinberger M; Muir K; Riegelman S
    J Pediatr; 1980 Nov; 97(5):825-8. PubMed ID: 7431179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction.
    Uematsu T; Follath F; Vozeh S
    Eur J Clin Pharmacol; 1986; 30(3):309-12. PubMed ID: 3732366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualization of oral theophylline dosage in elderly patients.
    Talseth T; Kornstad S; Boye NP; Bredesen JE
    Acta Med Scand; 1981; 210(6):489-92. PubMed ID: 7331897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent theophylline elimination in an adult.
    Creger RJ; Ball WD; Bahntge MF
    Drug Intell Clin Pharm; 1983 Mar; 17(3):202-5. PubMed ID: 6839945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline kinetics and ventilatory flow in bronchial asthma and chronic airflow obstruction: influence of erythromycin.
    Richer C; Mathieu M; Bah H; Thuillez C; Duroux P; Giudicelli JF
    Clin Pharmacol Ther; 1982 May; 31(5):579-86. PubMed ID: 7075107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of dosing time on the pharmacokinetics and pharmacodynamics of a 'once-a-day' sustained release theophylline preparation.
    Lamont H; Pauwels R; Van der Straeten M
    Br J Clin Pharmacol; 1987 Dec; 24(6):735-42. PubMed ID: 3440095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three methods for estimating theophylline pharmacokinetics.
    Coleman RW; Hedberg RL
    Clin Pharm; 1983; 2(2):148-52. PubMed ID: 6688390
    [No Abstract]   [Full Text] [Related]  

  • 16. Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose.
    Horai Y; Ishizaki T; Sasaki T; Watanabe M; Kabe J
    Eur J Clin Pharmacol; 1982; 23(2):111-21. PubMed ID: 7140800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of erythromycin stearate on serum theophylline concentration in patients with chronic obstructive lung disease.
    Stults BM; Felice-Johnson J; Higbee MD; Hardigan K
    South Med J; 1983 Jun; 76(6):714-8. PubMed ID: 6857302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disposition of theophylline in blood in chronic obstructive lung disease.
    Ebden P; Banks J; Peel T; Buss DC; Routledge PA; Spragg BP
    Ther Drug Monit; 1986; 8(4):424-6. PubMed ID: 3824427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use of controlled-release theophylline in chronic airways obstruction.
    Dal Negro R; Turco P; Pomari C; Cordaro CI
    J Int Med Res; 1987; 15(6):391-6. PubMed ID: 3436486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity.
    Jacobs MH; Senior RM; Kessler G
    JAMA; 1976 May; 235(18):1983-6. PubMed ID: 946508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.